Personalized Evidence-based Medicine in Patients With Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

4,200

Participants

Timeline

Start Date

January 10, 2021

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke
Interventions
DRUG

anticoagulation treatment

Adherence to personalized evidence-based anticoagulant treatment in patients at high risk for stroke with atrial fibrillation

Trial Locations (1)

630090

Evgeny Pokushalov, Novosibirsk

All Listed Sponsors
collaborator

Center for New Medical Technologies, Novosibirsk, Russia

OTHER

collaborator

I.M. Sechenov First Moscow State Medical University

OTHER

collaborator

University of Rochester

OTHER

collaborator

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

OTHER

lead

Center of Personalized Medicine, Pirogova

OTHER

NCT04774341 - Personalized Evidence-based Medicine in Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter